Parkinson's disease other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
'''PET scan''': In [[PET scan]] we can see that the uptake of [18F]-flurodopa tracer in reduce in the [[Caudate nucleus|caudate]] and [[putamen]] in [[Parkinson's disease|PD]] patients.[[Image:PET scan Parkinson's Disease.jpg|thumb|left|200px|18F PET scan shows decreased dopamine activity in the [[basal ganglia]], a pattern which aids in diagnosing Parkinson's disease.]] | '''PET scan''': In [[PET scan]] we can see that the uptake of [18F]-flurodopa tracer in reduce in the [[Caudate nucleus|caudate]] and [[putamen]] in [[Parkinson's disease|PD]] patients.<ref name="pmid20669302">{{cite journal |vauthors=Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, van Oostrom JC, Leenders KL |title=Typical cerebral metabolic patterns in neurodegenerative brain diseases |journal=Mov. Disord. |volume=25 |issue=14 |pages=2395–404 |date=October 2010 |pmid=20669302 |doi=10.1002/mds.23291 |url=}}</ref>[[Image:PET scan Parkinson's Disease.jpg|thumb|left|200px|18F PET scan shows decreased dopamine activity in the [[basal ganglia]], a pattern which aids in diagnosing Parkinson's disease.]] | ||
<br clear="left" /> | <br clear="left" /> | ||
Revision as of 07:16, 18 April 2018
|
Parkinson's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parkinson's disease other imaging findings On the Web |
|
American Roentgen Ray Society Images of Parkinson's disease other imaging findings |
|
Risk calculators and risk factors for Parkinson's disease other imaging findings |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Other Imaging Findings
PET scan: In PET scan we can see that the uptake of [18F]-flurodopa tracer in reduce in the caudate and putamen in PD patients.[1]
References
- ↑ Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, van Oostrom JC, Leenders KL (October 2010). "Typical cerebral metabolic patterns in neurodegenerative brain diseases". Mov. Disord. 25 (14): 2395–404. doi:10.1002/mds.23291. PMID 20669302.